by CU Anschutz Medical Campus Credit: Unsplash/CC0 Public Domain Researchers from the University of Colorado Anschutz Medical Campus have identified a potential new immune checkpoint receptor that could lead to treatments for diseases such as lung and bowel cancer and autoimmune conditions including IBD. The study, published today in Science Immunology, examines a family of 13 receptors, or...
